Securisyn Medical Announces U.S. Military Health System Distribution Agreement with Panakeia
March 16, 2023 - Securisyn Medical today announced the signing of a Service-Disabled Veteran-Owned Small Business (SDVOSB) Government Reseller Agreement with Panakeia, LLC of Naples, FL to distribute adult SolidAIRity® Oral Endotracheal Tube (ETT) Stabilization. The new Contract allows Securisyn Medical and Panakeia to partner to bring novel ventilated patient safety solutions to our military and specified federal government customers.
Securisyn awarded its second Advanced Industries Early Stage Capital and Retention Grant from the Colorado Office of Economic Development and International Trade
November 17, 2022 - Securisyn Medical announced today the Colorado Office of Economic Development and International Trade (OEDIT) has awarded the Company a $249,750 Advanced Industries Early Stage Capital and Retention Grant to accelerate design freeze, verification and validation testing, and clinical builds for the Company’s patented chest tube seal and securement device, SolidAIRity Sentry CT™.
Securisyn seeks up to $5M Crowd SAFE Raise for Commercialization
November 02, 2022 - Securisyn Medical announced today the launch of its $5 Million Crowd SAFE Crowdfunding campaign with Republic, a leading financial technology firm that allows everyone to invest in private markets.
Securisyn Awarded Technology Breakthroughs Contract with Premier, Inc.
October 3, 2022 - Securisyn Medical has been awarded a group purchasing agreement with Premier Inc., as part of their Technology Breakthroughs program. This new agreement, effective January 1, 2023, will allow Premier’s alliance of over 4,400 U.S. hospitals and health systems, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for SolidAIRity Flex®. SolidAIRity Flex®.
SunMed receives the European Union (EU) Medical Device Regulation (MDR) certification
September 12, 2022 - SunMed, a global leader in consumable medical devices for anesthesia and respiratory care, has received Medical Device Regulation (MDR) certification from the European Union (EU) on nine categories of its medical devices.
Securisyn Awarded Phase II of NIH $1.95M SBIR Fast-Track Grant
July 27, 2021 - Securisyn Medical today announced the Phase II award of its Phase I/II Fast-Track Small Business Innovation Research (SBIR) grant by the Eunice Kennedy National Institute of Child Health and Human Development (NICHD). The NICHD, which is part of the National Institutes of Health (NIH), awarded the collaborative grant in response to successful completion of the Phase I objectives, originally awarded and initiated in September of 2021. This Phase II award further supports Securisyn’s development and clinical testing of its novel neonatal and pediatric endotracheal securement devices.
Securisyn Announces Strategic Manufacturing and Distribution Partnership with SunMed
July 12, 2022 - Securisyn Medical and SunMed Group Holdings, a leading North American manufacturer and distributor of one of the world"s most comprehensive portfolios of consumable medical devices for anesthesia and respiratory care, today announced a robust strategic partnership. Both organizations will collate their respective expertise in the engineering, design, manufacturing, and distribution of novel airway securement devices serving the care continuum for all patient groups.
Nam Trinh Promoted to Chief Operating Officer
March 4, 2022 - Securisyn Medical announced today that Nam Trinh has been promoted to Chief Operating Officer for the Company. Mr. Trinh was Securisyn Medical’s Vice President of Supply Chain and Compliance and has been in that role since joining the Company in April of 2019. Prior to coming to Securisyn, Nam served as Vice President of Product Development & Quality Engineering at RMO, Inc., a Denver-based leading private manufacturer of orthodontic devices and products distributed globally.
Troy Noem elected to Securisyn’s Board of Managers
December 22, 2021 - Securisyn Medical announced today that the Company’s Board of Managers has elected Troy Noem to the Board. Additionally, the Board has appointed Mr. Noem to serve on the Finance & Audit Committee. With the addition of Mr. Noem, the Securisyn Medical Board will expand to five members, two of whom will be independent. Mr. Noem had previously served on the Company’s Advisory Board from 2018 through 2020 and is currently the Chief Financial Officer for Nuclear Care Partners.
Securisyn Announces Planned Leadership Transition of Co-Founder, Elyse Blazevich
October 27, 2021 - Securisyn Medical announced today that as part of a planned evolution to successfully scale commercial expansion, Elyse Blazevich, Co-Founder, will transition out of her day-to-day operating role as Chief Operating and Chief Financial Officer, to assume the role of President & CEO of the Colorado BioScience Association. Blazevich will remain integrally involved in the strategic oversight of Securisyn as a Co-Founder, member of the Board of Managers and Chair of the Finance & Audit Committee.
Securisyn awarded a $1.95M SBIR Grant by the Eunice Kennedy National Institute of Child Health and Human Development
September 20, 2021 - Securisyn Medical announced the award of a Fast-Track Small Business Innovation Research (SBIR) grant by the Eunice Kennedy National Institute of Child Health and Human Development (NICHD). The NICHD awarded the collaborative grant to support Securisyn’s development and clinical testing of its novel neonatal and pediatric endotracheal securement devices.
Patrick Howe Joins Securisyn Medical as Chief Commercialization Officer
August 31, 2021 - Securisyn Medical is pleased to announce that Patrick Howe has joined the Company as its Chief Commercialization Officer, effective August 31st, 2021.
Alan Green Joins Securisyn Medical as Chief Marketing Officer
April 1, 2021 - Securisyn Medical is pleased to announce that Alan (Al) Greene has joined the Company as its Chief Marketing Officer, effective April 1st, 2021.
Securisyn Medical Selected to The West Coast Consortium for Technology & Innovation in Pediatrics (CTIP)
February 21, 2020 - Securisyn Medical announced today that the company has been selected to join The West Coast Consortium for Technology & Innovation in Pediatrics (CTIP), a pediatric medical device accelerator centered at Children’s Hospital Los Angeles (CHLA) and the University of Southern California (USC). Securisyn, a Colorado-based medical device company, has been working to develop an innovative pediatric endotracheal tube (ETT) securement device that leverages the novel locking stabilizer technology of its recently FDA-cleared adult ETT stabilization system, SolidAIRity™ III, with the aim of reducing the rate of unplanned extubation (UE), the premature, unplanned removal of a life-sustaining breathing tube in children.
Securisyn Medical Receives Investment from Mayo Clinic to Fully Subscribe Its $2.5M Seed Round
February 11, 2020 Securisyn Medical, LLC, dedicated to airway management safety, announced today that it has received an investment from Mayo Clinic that fully subscribes its $2.5M seed round. This investment represents a major milestone for Securisyn’s established relationship with Mayo Clinic and comes at a time of significant momentum for the business. Securisyn’s flagship product, SolidAIRity(TM) III, recently received FDA 510(k) clearance and is scheduled for a limited market release during the first quarter of 2020.
Securisyn Medical Awarded Fourth Air Force Contract for Innovation
November 13, 2019 The United States Air Force has awarded Securisyn a $749,000 Small Business Innovation Research (SBIR) Phase II contract. Under the contract, Securisyn will prototype and refine a chest tube securement device based on the Company’s proprietary integrated restraint system (IRS) technology and design concept, SolidAIRity CT. The prototype device will be designed to meet the needs of providers throughout the continuum of care in Air Force and civilian health care systems.
Securisyn Medical Awarded Third Air Force Contract for Innovation
November 5, 2019 The United States Air Force has awarded the Company a $749,000 Small Business Innovation Research (SBIR) Phase II contract. Under this contract, Securisyn will prototype and refine an endotracheal tube securement device based on the Company’s proprietary interlocking restraint system (IRS) technology, the SolidAIRity III Airway Stabilization System. This prototype device will be optimized to meet the unique challenges and austere environments of pre-hospital providers in the Air Force medical community.
Securisyn Receives FDA 510(k) Clearance for its SolidAIRity™ III Airway Stabilization System
October 9, 2019 Securisyn announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its SolidAIRity™ III Airway Stabilization System for airway management of patients requiring oral intubation. The company, dedicated to making airway management safer, has pioneered the first, fully integrated airway stabilization system designed and patented to provide unmatched airway stability for ventilated patients.
Securisyn Awarded Second Air Force Contract for Innovation
August 24, 2019 The United States Air Force has awarded the Company a $50,000 Small Business Innovation Research Phase I contract. Under this contract, Securisyn will work with USAF Medical Providers to determine if the SolidAIRity CT is a superior method to prevent inadvertent chest tube dislodgement, which occurs throughout all echelons of the military healthcare system in deployed and operational environments.
Securisyn partners with Meddux Development to support new Product Pipeline
August 12, 2019 Under this partnership, Securisyn will work with Meddux to help generate near-term concept prototypes for the purpose of gaining user feedback and examining product viability around Securisyn’s proprietary integrated restraint system technology and related design concepts.
Securisyn joins Coalition for Unplanned Extubation Awareness and Prevention
July 3, 2019 The coalition’s collective goal is to raise awareness about UE and work with hospitals to implement standardized policies and procedures, and begin tracking and implementing quality measures.
Securisyn joins Mayo Clinic and ASU's MedTech Accelerator
April 24, 2019 The accelerator kicks off with an immersion program April 22–May 3 at Mayo Clinic's Arizona campus. Attending this event are Co-Founder Elyse Blazevich and President and CEO, Mark Bruning.
Securisyn Medical Joins the Catalyst HTI Ecosystem
March 20, 2019 Securisyn Medical, proudly announces that we have joined the Catalyst HTI ecosystem in Denver, Colorado.
Securisyn Medical Submits 510(K) to U.S. FDA for SolidAIRity™ III Airway Stabilization System
March 12, 2019 Securisyn Medical, LLC, today announced the 510(k) Premarket Notification submission to the U.S. Food and Drug Administration for its proprietary SolidAIRity™ III Airway Stabilization System.
Securisyn Medical Awarded Air Force Contract for Innovation
March 8, 2019 Securisyn Medical, LLC, announced today that the United States Air Force (USAF) has awarded the Company a $158,000 Small Business Innovation Research (SBIR) Phase I contract through the U.S. Air Force Inaugural Pitch Day competition in New York City.
Securisyn Medical selected to attend Inaugural US Air Force Pitch Day
February 22, 2019 Securisyn Medical, LLC, today announced they are one of 59 companies selected out of hundreds nationally to present its novel technology in support of the Company’s Air Force Small Business Innovation Research Phase I proposal at the Inaugural Air Force Pitch Day event on March 6-7, 2019 in New York City.
Securisyn Medical awarded $250,000 Early Stage Capital and Retention Grant
November 19, 2018 The Colorado Office of Economic Development and International Trade (OEDIT) has awarded Securisyn Medical a $250,000 Early Stage Capital and Retention Grant to accelerate required FDA 510(k) testing and post-clearance clinical trials for the Company’s patented airway stabilization system, SolidAIRity™.
Dr. Kanowitz Joins Airway Safety Taskforce
July 5, 2018 Dr. Arthur Kanowitz has been appointed to the board of the Patient Safety Movement's Airway Safety Taskforce.